Key Takeaways
- Ozempic costs about $968 to $1,150 per month in cash without insurance in 2026.
- With commercial insurance, copays range from $25 to $500 depending on formulary tier and deductible.
- The Novo Nordisk savings card can drop eligible commercial copays to $25 per fill.
- Compounded semaglutide alternatives run $179 to $499 monthly.
Direct answer (40-60 words, snippet-optimized)
Ozempic costs about $968 to $1,150 per month in cash without insurance in 2026. With commercial insurance, copays range from $25 to $500 depending on formulary tier and deductible. The Novo Nordisk savings card can drop eligible commercial copays to $25 per fill. Compounded semaglutide alternatives run $179 to $499 monthly.
Table of contents
- The 30-second answer
- Ozempic list price vs what you actually pay
- Cash price by dose at major pharmacies
- Insured cost: five real-world copay scenarios
- The Novo Nordisk savings card
- Medicare and Medicaid coverage
- Why your copay might be higher than expected
- Ozempic vs other GLP-1 prices
- Compounded semaglutide as a cash alternative
- How to lower your Ozempic cost in 6 steps
- International price comparison
- FAQ
- Footer disclaimers
Ozempic list price vs what you actually pay
Ozempic's wholesale acquisition cost (WAC), set by Novo Nordisk, is $968.52 per pen as of 2026. That number is the starting point. What you pay depends on a chain of middlemen, each of which adds or removes dollars before the prescription reaches you.
See transparent compounded pricing
Review compounded GLP-1 pricing and what provider-reviewed care includes, with no surprises at checkout.
Try the Cost Calculator →The chain looks like this:
- Novo Nordisk publishes the WAC ($968.52)
- Pharmacy benefit managers (PBMs) negotiate rebates with Novo Nordisk on behalf of insurance plans
- Insurance plans set a formulary tier and a copay structure for their members
- Pharmacies dispense the drug at the negotiated rate
- You pay the copay or the cash price at the counter
The WAC almost never matches the cash price you see at a pharmacy. Cash prices in 2026 typically run $940 to $1,150 depending on the chain, location, and any coupon programs in play. The variation is small in absolute terms but real.
Cash price by dose at major pharmacies (Q1 2026)
| Pharmacy | 0.25/0.5 mg starter | 1 mg | 2 mg | 8 mg high-dose |
|---|---|---|---|---|
| Walmart | $940 to $1,025 | $980 to $1,100 | $1,000 to $1,150 | $1,025 to $1,175 |
| CVS | $980 to $1,080 | $1,025 to $1,150 | $1,050 to $1,180 | $1,075 to $1,200 |
| Walgreens | $970 to $1,070 | $1,015 to $1,140 | $1,040 to $1,170 | $1,065 to $1,190 |
| Costco (members) | $885 to $960 | $895 to $980 | $920 to $1,005 | $940 to $1,025 |
| Sam's Club (members) | $895 to $975 | $920 to $1,005 | $940 to $1,025 | $960 to $1,050 |
| Kroger | $960 to $1,060 | $1,000 to $1,125 | $1,025 to $1,150 | $1,050 to $1,175 |
Costco and Sam's Club consistently win on cash price among the major chains. The membership cost ($60 to $120 per year) usually pays for itself within one fill if you're a regular Ozempic patient.
Insured cost: five real-world copay scenarios
The phrase "Ozempic price with insurance" is almost meaningless in isolation. What you pay depends on five variables: formulary tier, deductible status, prior authorization, diagnosis on the prescription, and any savings card layered on top.
Five anonymized real-world scenarios from FormBlends patient intake data:
Scenario 1: Employer PPO, well-funded plan. BlueCross BlueShield through a Fortune 100 employer. Ozempic on Tier 2 (preferred brand). Copay $40 after deductible. Deductible met in March. Monthly cost from April through December: $40.
Scenario 2: ACA Marketplace silver plan. Healthcare.gov silver plan, $4,000 deductible, 30% coinsurance on Tier 3 drugs. Negotiated price $850. Until deductible met: full $850. After: $255 per fill.
Scenario 3: High-deductible HSA plan. $3,500 deductible, $50 copay after. First three fills at full negotiated rate ($890). Fills 4 onward: $50.
Scenario 4: Medicare Part D. 67-year-old retiree, Part D plan. Ozempic for type 2 diabetes covered with a $250 specialty copay. Coverage gap kicks in around fill 8. Average annual out-of-pocket: $3,200.
Scenario 5: Self-pay, no insurance. Self-employed, no current coverage. Walmart cash price $1,025. With GoodRx coupon: $885. With Sam's Club membership: $945.
The takeaway: a "with insurance" copay anywhere from $25 to $500 is normal depending on the plan. Patients with Tier 2 employer coverage and a met deductible pay the least.
The Novo Nordisk savings card
Novo Nordisk's manufacturer copay assistance program is the single most-used cost reducer for Ozempic.
Eligibility:
- Commercial insurance that covers Ozempic for type 2 diabetes
- U.S. resident
- Not enrolled in Medicare, Medicaid, TRICARE, VA, or any government program
- Prescription is for FDA-approved indication (type 2 diabetes), not off-label weight loss
What it does:
- Reduces eligible commercial copays to as little as $25 per fill
- Maximum benefit of approximately $150 per fill
- Limit of 24 fills total
- Cannot stack with GoodRx or other discount programs
How to use it:
- Download from NovoCare.com or get a physical card from your provider
- Present alongside your insurance card at the pharmacy
- Pharmacist runs insurance first, applies savings card to copay
About 25% of new commercial-insured Ozempic patients qualify and use the card, per Novo Nordisk's published utilization data.
Medicare and Medicaid coverage
Medicare Part D plans cover Ozempic for type 2 diabetes, not for weight loss. Coverage tiers vary, but Ozempic almost always lands on a specialty tier with copays ranging from $200 to $500 per fill. The Inflation Reduction Act caps total annual Part D out-of-pocket spending at $2,000 starting in 2025, which limits the worst-case annual cost.
Medicare patients are not eligible for the Novo Nordisk commercial savings card. Lower-income Medicare beneficiaries may qualify for Extra Help (Low-Income Subsidy), which reduces specialty tier copays to about $11 per fill.
Medicaid coverage varies by state. Most state Medicaid programs cover Ozempic for type 2 diabetes with prior authorization. Coverage for weight loss is uncommon. Check your state's preferred drug list.
TRICARE covers Ozempic for type 2 diabetes with the standard formulary copay (about $14 to $40 per fill at military pharmacies). Weight-loss use is not covered.
VA covers Ozempic for veterans with type 2 diabetes through the standard VA pharmacy formulary at no copay or a small copay depending on service-connected status.
Why your copay might be higher than expected
Five common reasons your Ozempic copay is higher than what you expected at the counter:
1. You haven't met your deductible. Most plans require you to spend a fixed amount (often $1,500 to $5,000) on healthcare before insurance starts covering medications at the lower copay. Until then, you pay the negotiated rate, which can be $700 to $900.
2. Ozempic is on a high formulary tier. Tier 3 (non-preferred brand) typically means 30% coinsurance. Tier 4/specialty can mean 30% to 50% coinsurance. A high tier turns a "$50 copay" expectation into a $300 reality.
3. Prior authorization isn't approved yet. About half of new Ozempic prescriptions require prior authorization. If yours is pending or denied, the pharmacy charges full negotiated rate. Approvals typically take 3 to 14 days.
4. The prescription is for off-label use. If your provider wrote the prescription for weight loss rather than diabetes, most plans deny coverage. The same medication for weight loss is sold as Wegovy (a different price and coverage status).
5. The plan changed at the start of the calendar year. January 1 resets deductibles and sometimes formulary placements. A medication that was $40 in December might be $400 in January until the new deductible is met.
If your copay is unexpectedly high, ask the pharmacist for a "test claim" breakdown. They can show you exactly which step of the chain produced the price.
Ozempic vs other GLP-1 prices
| Medication | Cash price (1 month) | With manufacturer savings card | FDA indication |
|---|---|---|---|
| Ozempic (semaglutide) | $968 to $1,150 | As low as $25 (commercial) | Type 2 diabetes |
| Wegovy (semaglutide) | $1,349 | As low as $0 (commercial) | Weight management |
| Mounjaro (tirzepatide) | $1,069 to $1,180 | As low as $25 (commercial) | Type 2 diabetes |
| Zepbound (tirzepatide) | $1,086 to $1,200 | As low as $25 (commercial) | Weight management |
| Rybelsus (oral semaglutide) | $968 to $1,050 | As low as $10 (commercial) | Type 2 diabetes |
| Trulicity (dulaglutide) | $886 to $987 | As low as $25 (commercial) | Type 2 diabetes |
| Victoza (liraglutide) | $885 to $980 | As low as $25 (commercial) | Type 2 diabetes |
Cash prices for the GLP-1 class cluster between $880 and $1,200 per month for brand-name products. Wegovy is the most expensive on a list-price basis. The savings cards bring eligible patients into a similar $0 to $25 range across most products.
Compounded semaglutide as a cash alternative
For patients without insurance coverage or with high copays, compounded semaglutide is the most common cash alternative.
FormBlends compounded semaglutide pricing:
- Starting at $179 per month for the standard titration plan
- Includes provider consultation, supplies, and shipping
- Predictable monthly billing, no insurance paperwork
How compounded differs from brand-name Ozempic:
- Compounded semaglutide is not FDA-approved
- It's prepared by a state-licensed compounding pharmacy in response to an individual prescription
- It's drawn from a vial with a U-100 insulin syringe rather than delivered by a pen
- It's typically cheaper because it skips the brand distribution and direct-to-consumer marketing chain
When compounded makes sense:
- Insurance doesn't cover Ozempic
- Copay is over $200 per month and unsustainable
- You want predictable monthly pricing
- You don't qualify for the savings card or PAP
When brand-name Ozempic makes more sense:
- Copay is under $50 with the savings card
- You qualify for Novo Nordisk's Patient Assistance Program (free Ozempic for low-income patients)
- You strongly prefer FDA-approved medications
- You need the convenience of a pre-filled pen
A licensed clinician should walk through the trade-offs before either option starts.
How to lower your Ozempic cost in 6 steps
Step 1: Verify your formulary placement. Log into your insurance member portal, search "semaglutide" or "Ozempic," and check the tier. If it's Tier 3 or specialty, expect a higher copay.
Step 2: Check prior authorization status. Ask your provider's office whether PA has been submitted and approved. A pending PA means full cash price at the counter.
Step 3: Apply the Novo Nordisk savings card. If you have commercial insurance, download the card from NovoCare.com. Eligible patients pay as little as $25.
Step 4: Compare pharmacies. Costco, Sam's Club, and Walmart usually beat CVS and Walgreens on cash price by $50 to $150 per fill. Membership warehouse pricing is the floor for cash patients.
Step 5: Check the Patient Assistance Program. NovoCare PAP provides free Ozempic to patients earning under 400% of the federal poverty level (about $60,240 individual, $124,800 family of 4) without prescription drug coverage.
Step 6: Consider compounded alternatives. If brand-name pricing isn't sustainable, compounded semaglutide through a licensed telehealth platform runs $179 to $499 per month. The tradeoffs (not FDA-approved, vial-and-syringe administration) need to be weighed by the patient and clinician.
International price comparison
Ozempic prices outside the United States are dramatically lower because most countries negotiate drug prices nationally rather than letting market forces set them.
| Country | Approximate monthly cost (USD equivalent) | Notes |
|---|---|---|
| Canada | $200 to $250 | Provincial drug plans cover most patients |
| United Kingdom | $90 to $110 | NHS supplies for type 2 diabetes |
| Germany | $135 to $160 | Statutory health insurance covers most |
| Australia | $120 to $145 | PBS (Pharmaceutical Benefits Scheme) coverage |
| Mexico | $250 to $350 | Cash payment common |
| United States | $968 to $1,150 cash | $25 to $500 with commercial insurance |
Importing Ozempic from another country is illegal under FDA rules and the Drug Supply Chain Security Act, even though the FDA has historically not prosecuted small personal-use orders. The risks include counterfeit product, supply chain breaks, and lack of recourse if the medication is defective.
FAQ
How much is Ozempic per month? Cash prices in 2026 run $968 to $1,150 per month at major U.S. pharmacies. With commercial insurance, monthly copays range from $25 (with the savings card) to $500 depending on plan structure.
Does insurance cover Ozempic? Most commercial insurance plans cover Ozempic for type 2 diabetes with a copay or coinsurance. Coverage for off-label weight loss is rare. Medicare Part D covers it for diabetes; Medicaid coverage varies by state.
How do I get Ozempic for $25 a month? Patients with commercial insurance covering Ozempic for type 2 diabetes can use the Novo Nordisk savings card to reduce eligible copays to as little as $25 per fill, up to 24 fills total.
Why is Ozempic so expensive? Novo Nordisk sets a high list price because the U.S. market lacks national price negotiation, R&D recovery is part of the price, and demand has consistently exceeded supply since 2022. International prices in countries with national negotiation are 70% to 90% lower.
What is the cheapest place to get Ozempic? Among major retail chains, Costco and Sam's Club typically offer the lowest cash prices ($885 to $1,005 per fill for members). For low-income uninsured patients, the Novo Nordisk Patient Assistance Program can provide Ozempic free of charge.
Is Ozempic cheaper than Wegovy? Yes. Ozempic has a list price of about $968 per month vs Wegovy at $1,349. Both contain semaglutide, but they are FDA-approved for different indications and aren't interchangeable on insurance.
Will Medicare pay for Ozempic? Medicare Part D covers Ozempic for type 2 diabetes with specialty tier copays of $200 to $500 per fill. Medicare does not cover Ozempic for weight loss. The 2025 IRA out-of-pocket cap of $2,000 limits annual exposure.
Can I use GoodRx for Ozempic? Yes, GoodRx coupons can lower the cash price by $80 to $200 per fill at participating pharmacies. GoodRx cannot be combined with insurance or with the Novo Nordisk savings card. You'd choose either coupon or insurance, not both.
How much does a 3-month supply of Ozempic cost? A 90-day fill at cash price runs roughly $2,800 to $3,400. Some insurance plans support 90-day fills for chronic medications, which can reduce copay processing fees compared to monthly fills.
Is compounded semaglutide cheaper than Ozempic? For uninsured patients or those with high copays, yes. Compounded semaglutide through telehealth platforms typically runs $179 to $499 per month vs $968 to $1,150 cash for Ozempic. Compounded products are not FDA-approved.
How can I get Ozempic for free? Novo Nordisk's Patient Assistance Program (NovoCare PAP) provides Ozempic free of charge to U.S. residents earning under 400% of the federal poverty level who have no prescription drug coverage and a prescription for type 2 diabetes.
Does the price of Ozempic include needles? The Ozempic pen has a built-in injection device, but the disposable needle tips (NovoFine 32G) are sold separately. A box of 100 needle tips runs $20 to $40. Some pharmacies bundle them with the prescription.
What's the price of Ozempic in 2026? The 2026 list price is approximately $968.52 per pen, with cash prices at retail pharmacies ranging from $940 to $1,200 depending on chain and location. Insurance copays range $25 to $500 per fill.
Will Ozempic prices go down? The Inflation Reduction Act selected semaglutide for Medicare price negotiation in 2027, which will lower the Medicare price starting in 2027. Commercial market prices typically follow Medicare prices with a lag, but no commercial price drop is announced for 2026.
Author / review note
Reviewed by the FormBlends Medical Team. References include Novo Nordisk's published WAC pricing (2026), the Centers for Medicare & Medicaid Services (CMS) Part D coverage data 2026, the Inflation Reduction Act drug price negotiation list (HHS, 2024), GoodRx pricing data accessed Q1 2026, and the NovoCare Patient Assistance Program eligibility guidelines 2026.
Related reading on FormBlends:
- /articles/cost-and-insurance/ozempic-walmart-price/
- /articles/comparison/ozempic-vs-wegovy/
- /articles/compounded-and-peptides/compounded-semaglutide-cost/
Sources
- Novo Nordisk's published WAC pricing (2026).
- The Centers for Medicare & Medicaid Services (CMS) Part D coverage data 2026.
- The Inflation Reduction Act drug price negotiation list (HHS, 2024).
- GoodRx pricing data accessed Q1 2026.
- The NovoCare Patient Assistance Program eligibility guidelines 2026.
Footer disclaimers (all 4 verbatim)
Platform Disclaimer. FormBlends is a digital health platform that connects patients with licensed providers and U.S.-based pharmacies. We do not manufacture, prescribe, or dispense medication directly. All clinical decisions are made by independent licensed providers.
Compounded Medication Notice. Compounded semaglutide and tirzepatide are not FDA-approved. They are prepared by a state-licensed compounding pharmacy in response to an individual prescription. Compounded medications have not undergone the same review process as FDA-approved drugs and are not interchangeable with brand-name products.
Results Disclaimer. Individual results vary. Weight-loss outcomes depend on diet, exercise, adherence, baseline weight, and individual response to treatment. Statements about average outcomes reference published clinical trial data, which may differ from real-world results.
Trademark Notice. Ozempic, Wegovy, and Rybelsus are registered trademarks of Novo Nordisk A/S. Mounjaro, Zepbound, and Trulicity are registered trademarks of Eli Lilly and Company. Victoza is a registered trademark of Novo Nordisk A/S. Walmart, CVS, Walgreens, Costco, Sam's Club, Kroger, and GoodRx are trademarks of their respective owners. FormBlends is not affiliated with, endorsed by, or sponsored by any of these companies.
Talk to a licensed provider
Start your free assessment. A licensed provider reviews every request before anything is prescribed, and not everyone qualifies.
Start the assessment →